Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.1M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
65.9M
-
Shares change
-
-5.79M
-
Total reported value, excl. options
-
$248M
-
Value change
-
-$30.7M
-
Put/Call ratio
-
2.41
-
Number of buys
-
68
-
Number of sells
-
-90
-
Price
-
$3.76
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) as of Q1 2025
183 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.9M shares
of 67.1M outstanding shares and own 98.15% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (6.84M shares), Paradigm Biocapital Advisors LP (6.74M shares), BVF INC/IL (5.3M shares), BlackRock, Inc. (3.82M shares), Deep Track Capital, LP (3.44M shares), Logos Global Management LP (3.21M shares), FRANKLIN RESOURCES INC (3.01M shares), MPM BIOIMPACT LLC (2.93M shares), VANGUARD GROUP INC (2.87M shares), and LIGHTSPEED MANAGEMENT COMPANY, L.L.C. (1.93M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.